论文部分内容阅读
We recruited consecutive patients with stage III epithelial ovarian, tubal, and peritoneal cancers who had optimalresidual tumor after primary cytoreductive surgery and who received intraperitoneal chemotherapy between 2002and 2012. Two propensity score-m